Nanobiotechnology: Cradle for revolution in drug carrier systems

Please use this identifier to cite or link to this item: http://localhost:80/xmlui/handle/123456789/13441

Full metadata record

DC Field	Value	Language
dc.contributor.author	Zafar, Saba	-
dc.contributor.author	Rasul, Akhtar	-
dc.contributor.author	Iqbal, Muhammad Shahid	-
dc.contributor.author	Rasool, Maria	-
dc.contributor.author	Ahmed, Bilal	-
dc.contributor.author	Qadir, Muhammad Imran	-
dc.date.accessioned	2022-10-20T10:00:06Z	-
dc.date.available	2022-10-20T10:00:06Z	-
dc.date.issued	2021-01-16	-
dc.identifier.issn	1011-601X	-
dc.identifier.uri	http://142.54.178.187:9060/xmlui/handle/123456789/13441	-
dc.description.abstract	: The role of nanobiotechnology in the treatment of diseases is limitless. In this review we tried to focus main aspects of nanotechnology in drug carrier systems for treatment and diagnosis of various diseases such as cancer, pulmonary diseases, infectious diseases, vaccine development, diabetes mellitus and the role of nanotechnology on our economy and its positive social impacts on our community. We discussed here about the different “Biotechnano Strategies” to develop new avenues and ultimately improve the treatment of multiple diseases.	en_US
dc.language.iso	en	en_US
dc.publisher	Karachi: Faculty of Pharmacy & Pharmaceutical Sciecnes, University of Karachi	en_US
dc.subject	Nanochemical products	en_US
dc.subject	infectious diseases	en_US
dc.subject	vaccines	en_US
dc.title	Nanobiotechnology: Cradle for revolution in drug carrier systems	en_US
dc.type	Article	en_US
Appears in Collections:	Issue 01

Files in This Item:

File	Description	Size	Format
Paper-25.htm		131 B	HTML	View/Open

DSpace JSPUI